Purdue Pharma Foquest Capsule Product Recall (2019-07-25)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Foquest 35 mg capsule;
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 135571 | - Recalling Firm
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
- Marketing Authorization Holder
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
| D. Foquest 85 mg capsule | Capsule (Controlled Release) | DIN 02470349 | Methylphenidate hydrochloride 85 mg |
| 135569 | - Recalling Firm
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
- Marketing Authorization Holder
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
| B. Foquest 45 mg capsule | Capsule (Controlled Release) | DIN 02470314 | Methylphenidate hydrochloride 45 mg |
| 134046 | - Recalling Firm
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
- Marketing Authorization Holder
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
| C. Foquest 70 mg capsule | Capsule (Controlled Release) | DIN 02470330 | Methylphenidate hydrochloride 70 mg |
| 135568 | - Recalling Firm
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
- Marketing Authorization Holder
- Purdue Pharma Canada
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
| Foquest 35 mg capsule; | Capsule (Controlled Release) | DIN 02470306 | Methylphenidate hydrochloride 35 mg |
-
Foquest 35 mg capsule;
-
Foquest 45 mg capsule;
-
Foquest 70 mg capsule;
-
Foquest 85 mg capsule;
Out of specification result for potency during shelf life testing